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The secondary resistome of 
multidrug-resistant Klebsiella 
pneumoniae
Bimal Jana1,2,*, Amy K. Cain3,†,*, William T. Doerrler4, Christine J. Boinett3,‡, Maria C. Fookes3, 
Julian Parkhill3 & Luca Guardabassi1,2
Klebsiella pneumoniae causes severe lung and bloodstream infections that are difficult to treat due 
to multidrug resistance. We hypothesized that antimicrobial resistance can be reversed by targeting 
chromosomal non-essential genes that are not responsible for acquired resistance but essential for 
resistant bacteria under therapeutic concentrations of antimicrobials. Conditional essentiality of 
individual genes to antimicrobial resistance was evaluated in an epidemic multidrug-resistant clone of 
K. pneumoniae (ST258). We constructed a high-density transposon mutant library of >430,000 unique 
Tn5 insertions and measured mutant depletion upon exposure to three clinically relevant antimicrobials 
(colistin, imipenem or ciprofloxacin) by Transposon Directed Insertion-site Sequencing (TraDIS). Using 
this high-throughput approach, we defined three sets of chromosomal non-essential genes essential 
for growth during exposure to colistin (n = 35), imipenem (n = 1) or ciprofloxacin (n = 1) in addition to 
known resistance determinants, collectively termed the “secondary resistome”. As proof of principle, 
we demonstrated that inactivation of a non-essential gene not previously found linked to colistin 
resistance (dedA) restored colistin susceptibility by reducing the minimum inhibitory concentration 
from 8 to 0.5 μg/ml, 4-fold below the susceptibility breakpoint (S ≤ 2 μg/ml). This finding suggests that 
the secondary resistome is a potential target for developing antimicrobial “helper” drugs that restore 
the efficacy of existing antimicrobials.
Antimicrobial resistance is an emerging global healthcare crisis with significant impact on human health and 
economy1. This crisis is worsened by the dearth of new antimicrobials, especially against Gram-negative patho-
gens, and by the spread of high-risk multidrug-resistant (MDR) clones. Of particular concern is the emergence 
of MDR Klebsiella pneumoniae strains resistant to carbapenems, a class of last resort antibiotics for treatment of 
severe Gram-negative infections2. Carbapenem resistance is mainly associated with the plasmid-borne blaKPC 
gene encoding carbapenem-hydrolyzing K. pneumoniae carbapenemase (KPC)3. In addition to blaKPC, MDR K. 
pneumoniae isolates carry an average of 11–13 acquired resistance genes, which confer resistance to virtually 
all antimicrobial agents available in clinical practice4. The emergence of carbapenem resistance has forced the 
reintroduction into clinical practice of colistin (CST), an antimicrobial peptide with known nephro- and neuro-
toxic effects5. Unfortunately, MDR KPC-producing K. pneumoniae such as the epidemic clone sequence type 258 
(ST258) have developed CST resistance largely by acquiring mutations in the chromosomal LPS-modification 
regulatory genes, which reduces negative charge on the bacterial surface and consequently affinity towards pos-
itively charged peptides6. To date, no genome-wide antimicrobial drug-gene interaction studies have been per-
formed to evaluate the contribution of individual genes to the resistance phenotype in this high-risk MDR clone.
The recent advances in next-generation sequencing combined with transposon mutagenesis has allowed 
development of novel tools to study gene-phenotype connections at the genome-scale and in a high-throughput 
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manner7,8. Such tools evaluate the involvement of each gene simultaneously in a particular condition by meas-
uring differences in transposon insertion abundance after applying selection to a saturated mutant library, com-
pared to a control. One of these tools, Transposon Directed Insertion-site Sequencing (TraDIS), has been used 
to identify essential genes, screen for virulence factors and genes essential for specific biological processes (e.g. 
sporulation), as well as novel targets for antimicrobial development9–11. This method provides a systems-level 
view of the interdependent gene networks that respond to stress, for example antimicrobial stress12. The useful-
ness and success of this method depend on the availability of saturated transposon insertion mutant libraries, 
which in turn rely on the transformation or transposition efficiency of the strain used for constructing the library.
In this study, we constructed the first saturated transposon mutant library of MDR KPC-producing K. pneu-
moniae ST258 and, for the first time in Klebsiella pneumoniae, we employed TraDIS. We evaluated the contri-
bution of each individual gene to resistance to three clinically important drugs which this strain is resistant to: 
colistin (CST; a polymyxin), imipenem (IPM; a carbapenem), and ciprofloxacin (CIP; a fluoroquinolone). TraDIS 
unveiled the existence of chromosomal non-essential genes that become essential in presence of therapeutic 
concentrations of antimicrobials. Considering that known antimicrobial resistance elements can be regarded as 
primary resistance genes, we designated these genes individually as “Secondary Resistance Genes” (SRGs) and 
collectively as the “Secondary Resistome” (SR) for each antimicrobial. As proof of principle, we demonstrated that 
inactivation of a SRG restored susceptibility to CST.
Results
MDR K. pneumoniae ST258 genome sequence. K. pneumoniae ST258 strain RH201207 (Table S1) is 
a clinical isolate obtained from Public Health England in 2012. RH201207 is resistant to CST, IPM and CIP with 
Minimal Inhibitory Concentrations (MICs) of 8, 16 and 32 μ g/ml, respectively. In addition, the strain displays 
resistance to aminoglycosides, chloramphenicol, macrolides, sulphonamides and trimethoprim. For this study, 
whole genome sequencing (WGS) of RH201207 was performed to develop the reference genome required for 
TraDIS analysis using a combination of PacBio and Illumina platforms, and annotated sequences were submit-
ted in European Nucleotide Archive (ENA) (accession numbers LT216436-LT216440). WGS identified 5.4 Mb 
of chromosomal sequence with 5798 genes, including 89 and 25 tRNA and rRNA encoding genes, respectively, 
an average GC content of 58.52% and four extrachromosomal plasmids with the size of 18, 42, 117 and 214 kb. 
Genome analysis revealed the presence of multiple resistance genes in the plasmid and chromosomal mutations 
conferring resistance to: β -lactams (blaTEM, blaSHV, blaOXA-9, and blaKPC-3), aminoglycosides (aac6′ and aph3), chlo-
ramphenicol (catA), macrolides (mphA), polymyxins (mutations in phoQ and an IS insertion in mgrB), quinolo-
nes (oqxAB), sulphonamides (sul1), and trimethoprim (dhfrA).
Construction of a high-density mutant library and TraDIS sequencing. A RH201207 mutant library 
of over 1 million individual mutants was constructed using modified Tn5 transposon13. Since the target strain was 
susceptible to tetracycline, a TetR resistance cassette was PCR amplified using Tn5 mosaic element tagged primers. 
The amplified cassette was incubated with Tn5 transposase to form an in vitro transposome complex, which was 
electroporated into competent RH201207, followed by mutant selection on agar supplemented with tetracycline. 
During competent cell preparation, growth media was supplemented with EDTA to increase the transformation 
efficiency by destabilizing the cell envelope14. Over 1 million colonies, each representing an individual mutant, 
were collected from multiple batches of electroporation and pooled. Saturation of transposon insertions over the 
ST258 genome was confirmed by TraDIS analysis15. Briefly, 32 million single ended 50 bp Illumina sequence reads 
of insertion sites were generated and mapped onto the full genome sequence of RH201207, leading to identifica-
tion of more than 431,000 unique transposon insertions distributed across the genome (Fig. 1A) with an average 
of one transposon insertion in every 19 nucleotides. Complete absence of insertions in genes previously known 
to be essential in K. pneumoniae, such as gyrA and nrdA16,17 (Fig. 1B), demonstrated the technical success of each 
step, from library construction to mapping of TraDIS insertion site reads over the genome (Table S3). Analysis of 
the unchallenged TraDIS library DNA showed that from 5798 genes, 642 genes were determined to be essential 
(11% of the genome) and 49 ambiguous, that is, not essential or non-essential, using the parameters defined in 
Dembek et al. 10.
Identification of non-essential genes important for growth with antimicrobials. The contri-
bution of each non-essential gene to antimicrobial resistance was evaluated by measuring depletion of trans-
poson insertion mutants from the population following exposure to CIP, CST and IPM. To mimic therapeutic 
levels, we chose a concentration (2 μ g/ml) that is 2 fold lower than the resistance breakpoint for these drugs 
(R ≥ 4 μ g/ml)18,19. TraDIS analysis was performed and the insertion density was compared for each gene between 
antimicrobial-exposed and unexposed (control) cultures. Genes with a significant mutant depletion during anti-
microbial exposure, as defined by a 4 fold or higher decrease in the number of insertion sites, were tabulated. In 
addition to known primary antimicrobial resistance genes and associated regulatory elements, namely oqxAB for 
CIP20, the arn/pmr operons for CST6 and blaKPC3 for IPM21, we identified 35 non-essential chromosomal genes/
operons involved in CST resistance (Table 1), and single chromosomal genes involved in resistance to CIP and 
IPM (Table 2).
A gene (dedA) encoding putative integral membrane protein (DedA) not previously known to be associated 
with CST resistance, displayed the highest mutant depletion within the library upon exposure to CST. Insertions 
detected in this SRG decreased by 512 fold in the presence of CST. The functional classification of the remaining 
34 CST SRGs identified by this study were membrane biogenesis (wabN, galE, galU, fabR, pgi, bamB, mrcB)22–26, 
putative ECA (enterobacterial common antigen) polymerase (RH201207_01572), maintenance of outer mem-
brane integrity (pal, tolQRAB)27, cell division (dedD, envC)28, presentation of virulence factors (galU)29,30, tran-
scription regulation (cpxR, hupA)31, membrane chaperone/protease (fkpA, degP), and energy metabolism (sdhD, 
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yhcB, fre)32,33 (Table 1). As expected, each gene in the arn operon, which is needed to confer CST resistance via 
modification of Lipid A, had a decreased insertion count in the presence of CST. In particular, inactive mutants in 
arnT and arnE were depleted by 256 fold in CST-exposed samples.
Interestingly, nhaA and ydiE were the only chromosomal genes identified in the SR of IPM and CIP, respec-
tively (Table 2). Therapeutic levels of IPM in the culture medium decreased insertion abundance by 4 fold for 
nhaA, which encodes a Na+/H+ antiporter34. Although ydiE displayed a 4-fold mutant depletion following expo-
sure to CIP, the q value was not significant (> 0.01). For this reason, this gene was not selected to perform addi-
tional experiments.
Effect of CST concentration on depletion of insertion mutants. To understand the dynamics of the 
mutant population at different CST concentrations, the library was also exposed to a lower concentration (0.8 μ g/ml), 
which corresponds to 1/10 of the MIC of CST in RH201207. Exposure to this drug concentration reduced the 
Figure 1. (A) Mapping of transposon insertion sites to the genome of Klebsiella pneumoniae ST258 RH201207. 
The chromosomal sequence is shown with open reading frames in cyan and the base positions are given in 
black. The inner ring represents the GC content (purple indicates values below average, whereas yellow-green 
indicates values above average). The red lines on the outer ring represent the numbers of Tn5 insertions at each 
position in the genome, which varies from 1 to 631. (B) Chromosomal section of the Transposon Directed 
Insertion-site Sequencing (TraDIS) insertion map of Klebsiella pneumoniae ST258. DNA was extracted from 
mutant library and TraDIS analysis was performed in duplicate, subsequently insertion site reads were plotted 
on the chromosomal sequence using Artemis. The figure shows that transposon insertions occurred in non-
essential genes (glpQ and rcsC) but not in essential genes (nrdA and gyrA).
www.nature.com/scientificreports/
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size of the CST SR from 35 to 7 SRGs (Table 1, Fig. 2), as well as the level of depletion of insertions for the 6 
SRGs that were also identified at the higher concentration. Insertions in the primary resistance operon (arnA-T) 
showed equivalent levels of depletion at high confidence at both CST concentrations. Similar to the arn operon, 
one SRG, RH201207_00408, encoding a putative glycosyltransferase involved in cell wall biosynthesis, was found 
with decreased insertions at both concentrations (Table 1). The other 6 genes that were found important at both 
concentrations are functionally involved in membrane biogenesis (dedA, wabN, RH201207_00413, galU and pgi) 
or maintenance of envelope integrity (pal). At the lower CST concentration, the SRG dedA had a less dramatic 
reduction in insertions, compared to the control, than the higher concentration (Fig. 3). Interestingly, four genes 
Gene/operon Function
Colistin 2 μg/ml Colistin 0.8 μg/ml
LogFC LogCPM q value LogFC LogCPM q value
dedA Putative integral membrane protein − 9.95 4.61 1.06E-48 − 2.93 4.78 3.74E-25
RH201207_02818 Hypothetical protein − 9.67 4.35 3.83E-41
wabN Deacetylase, involved in lipopolysaccharide (LPS) biosynthesis − 9.33 6.34 4.77E-144 − 4.77 6.39 5.84E-110
galE UDP-galactose 4-epimerase, involve in LPS biosynthesis − 9.09 3.80 4.73E-30
wzabc Putative role in capsule polysaccharide (CPS) synthesis and outer membrane export of CPS − 8.52 6.90 1.09E-236
arnBCADTE Known resistance cassette, responsible for lipid A modification − 8.12 7.20 1.26E-292 − 7.25 7.21 5.14E-295
lpp Murein lipoprotein, plays role in membrane biogenesis and integrity maintenance − 8.03 2.83 1.17E-15
surA Periplasmic peptidylprolyl cis-trans isomerase chaperone, involved in correct folding and assembly of outer membrane proteins − 7.99 2.79 2.49E-13
RH201207_00408 Putative glycosyltransferase involved in cell wall biosynthesis − 7.65 2.49 3.98E-12 − 7.69 2.47 1.16E-11
RH201207_00413 Putative O-antigen ligase, involved in LPS biogenesis − 7.63 4.67 3.51E-48 − 2.20 4.94 1.19E-17
rnhA Ribonuclease H, endonuclease that specifically degrades the RNA of RNA-DNA hybrids − 6.71 1.72 1.34E-06
galU Have role in LPS biosynthesis and involved in virulence − 6.61 1.65 3.57E-06 − 2.56 1.78 0.016688
fabR Transcriptional repressor of cognate genes that involve unsaturated fatty acid biosynthesis − 6.55 5.91 8.49E-108
RH201207_00757 Putative membrane protein − 6.22 7.97 0
Pgi Glucose-6-phosphate isomerase, housekeeping gene involved in membrane biosynthesis − 5.72 3.69 1.92E-23 − 3.15 3.79 1.01E-14
bamB Subunit of outer membrane protein assembly complex − 5.27 3.28 2.85E-16
tolQRAB Maintain envelope integrity − 5.24 3.25 7.52E-18
Pal Peptidoglycan-associated lipoprotein that contributes to serum resistance, maintains envelope integrity − 5.21 2.46 2.96E-10 − 2.41 2.62 0.000517
dedD Putative cell division associated protein − 5.12 4.30 8.89E-26
sdhD Putative succinate dehydrogenase complex subunit − 4.87 2.18 5.22E-08
hupA Transcriptional regulator HU subunit alpha − 4.36 2.49 1.85E-09
yhcB ubiquinol oxidase subunit III − 4.29 1.73 2.34E-05
RH201207_03912 Putative glycosyltransferase, involved in LPS biogenesis − 4.18 9.40 0
gspA/rfbD Hypothetical protein − 4.17 9.81 0
fkpA FKBP-type peptidyl-prolyl cis-trans isomerase − 3.92 6.99 3.02E-114
degP Periplasmic serine endo-protease − 3.85 7.04 3.74E-138
RH201207_05041/42 Hypothetical lipoprotein − 3.65 3.41 1.29E-12
tagA Hypothetical lipoprotein − 3.53 6.18 9.63E-66
cysC Putative adenylyl sulfate − 3.41 5.17 4.18E-30
ydgA Hypothetical protein − 3.36 6.31 1.09E-78
RH201207_01572 Putative ECA polymerase − 3.26 4.08 1.58E-19
cpxR Response regulator receiver domain of envelope stress response two-component system − 3.06 3.23 7.80E-10
fre FMN reductase − 2.67 4.99 1.26E-17
mrcB penicillin binding protein 1b − 2.66 7.13 5.38E-114
miaA Putative tRNA delta(2)-isopentenyl-pyrophosphate transferase − 2.47 3.14 3.87E-07
envC Septal ring factor EnvC − 2.27 4.53 5.27E-11
Table 1.  The colistin secondary resistome in Klebsiella pneumoniae ST258. Genes/operons for which 
insertion sequence abundance was significantly (≥ 4 fold) depleted when the mutant library was cultured in the 
presence of 2 μ g/ml or 0.8 μ g/ml of colistin were identified by Transposon Directed Insertion-site Sequencing 
(TraDIS) analysis. Differences in insertion sequence abundance compared to the unexposed (control) culture 
of the library are expressed by log2 fold change (logFC). Number of insertion site sequence reads for the 
mentioned gene are presented by log2 counts per million (LogCPM). Quality of data is indicated by (q) value, 
where q ≤ 0.01 is significant. Known colistin resistance genes are presented in bold.
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(galE, lpp, surA and RH201207_02818) involved in membrane biogenesis were implicated in resistance at the 
higher concentration but not at the lower one.
Confirmation of selected SRGs involvement in antimicrobial resistance. The two genes dedA and 
nhaA, which were identified by TraDIS analysis as the SRGs with the largest reduction in insertion levels during 
CST and IPM exposure, respectively, were each knocked out individually by Lambda Red recombination35,36. 
While no reduction in the MIC of IPM was observed when nhaA was deleted, targeted deletion of dedA rendered 
RH201207 susceptible to CST as evidenced by a 16-fold reduction of the MIC from 8 to 0.5 μ g/ml. Sequencing of 
the dedA mutant confirmed successful removal of dedA and no secondary mutations (Fig. S1). This dedA mutant 
was also successfully complemented via induction of DedA from arabinose inducible promoter of a synthetic 
plasmid (pBAD) carrying dedA, which restored CST resistance in the deletion mutant (Fig. S2). Deletion of dedA 
did not reduce the fitness of strain, as the growth rate of the mutant matches the wild type in drug-free medium 
(Fig. S3). Further, the effect of removing dedA was drug-specific as the mutant did not display altered MIC for any 
other antimicrobials tested, beyond CST (data not shown). To test the possibility of spontaneous reversion of CST 
resistance via suppressor mutations, MIC plates were incubated for multiple days, and no growth was observed 
after additional incubation.
DedA homology to human and bacterial proteins. In silico analysis using NCBI-BLAST tools (http://
blast.ncbi.nlm.nih.gov) did not find any homology of DedA from K. pneumoniae to human protein. Proteins 
homologous to dedA from other Enterobacteriaceae, including Salmonella enterica, Shigella flexneri, Citrobacter 
Gene/operon Function
Imipenem Ciprofloxacin
LogFC LogCPM q value LogFC LogCPM q value
nhaA pH dependent Na+ /H+ antiporter − 2.22 4.51 2.38E-13
ydiE hypothetical protein − 2.67 2.20 0.013926
Table 2.  The imipenem and ciprofloxacin secondary resistomes in Klebsiella pneumoniae ST258. Genes/
operons for which insertion sequence abundance was significantly (≥ 4 fold) depleted when the mutant library 
was cultured in the presence of 2 μ g/ml of imipenem or ciprofloxacin were identified by Transposon Directed 
Insertion-site Sequencing (TraDIS) analysis. Differences in insertion sequence abundance compared to the 
unexposed (control) culture of the library are expressed by log2 fold change (logFC). Number of insertion site 
sequence reads for the mentioned gene are presented by log2 counts per million (LogCPM). Quality of data is 
indicated by (q) value, where q ≤ 0.01 is significant.
Figure 2. Venn diagram of the colistin (CST) secondary resistance genes (SRGs) detected in Klebsiella 
pneumoniae ST258 upon exposure to different drug concentrations. The diagram shows the overlap between 
the SRGs detected by Transposon Directed Insertion-site Sequencing (TraDIS) analysis after exposure of the 
K. pneumoniae ST258 mutant library to 2 μ g/ml (dark grey circle) and 0.8 μ g/ml (light grey circle) of CST, 
respectively.
www.nature.com/scientificreports/
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freundii, and Escherichia coli were identified as having high amino acid sequence identity. Proteins with ≥ 90% 
sequence identity were identified as hypothetical DedA family proteins and displayed ≥ 94% query coverage with 
minimum E value of 2e-144, indicating that dedA is conserved across Enterobacteriaceae.
Discussion
This study reveals a complete set of SRGs that are implicated in resistance to three clinically relevant antimi-
crobials that, excluding known resistance genes, collectively make up the SR of MDR K. pneumoniae ST258. 
Although these genes were not previously known to be associated with antimicrobial resistance, their function-
ality was demonstrated to be important only when this high-risk clone was cultured in the presence of antimi-
crobials. Conditional gene essentiality was first assessed based on significant (≥ 4 fold) decreases in the number 
of transposon insertions observed during antimicrobial exposure, as measured by TraDIS. This approach was 
shown to be valid for identification of SRGs, since insertions in the known primary CST resistance determinant 
(arn operon) were drastically reduced after exposure to CST. Using TraDIS, the contribution of each chromo-
somal non-essential gene to any given phenotype can be determined in a high-throughput manner by combin-
ing large-scale mutagenesis and next-generation sequencing. This approach is less labour intensive compared to 
signature-tagged mutagenesis, which has been used extensively to identify virulence genes in K. pneumoniae37.
The size of the CST SR decreased when the library was exposed to a lower concentration of CST, suggesting 
a concentration-dependent involvement of the cellular metabolic processes, where resistance mechanisms seem 
to become more complex at higher levels of CST. It has been previously shown that gene expression profiles of 
Acinetobacter baumannii are substantially altered depending on the exposure dose of polymyxins38. The SRGs 
that were detected at both high and low concentrations are functionally involved in membrane biogenesis and 
maintenance of envelope integrity, whereas those only detected at high concentration are related to the core pro-
cesses of transcription regulation, stress response, cell division and energy metabolism, in addition to membrane 
biogenesis (Table 1). These results indicate the key importance of the membrane biogenesis and maintenance 
machinery for CST resistance.
We demonstrated that CST susceptibility is restored by inactivation of the SRG dedA, which was identified by 
TraDIS analysis as the gene with the highest decrease in insertions during CST exposure. Targeted inactivation 
of dedA restored CST susceptibility by reducing the MIC of the wild type strain from 8 μ g/ml to the 0.5 μ g/ml. 
This is well below the susceptibility breakpoints (S ≤ 2), as defined by the European Committee on Antimicrobial 
Susceptibility Testing (EUCAST) for Enterobacteriaceae19 and by the Clinical and Laboratory Standards Institute 
(CLSI) for other Gram-negative pathogens such as Pseudomonas aeruginosa and Acinetobacter spp18. This is a 
proof of principle that CST resistance can be reversed by targeting a non-essential gene that until today has not 
been linked to this antibiotic resistance. Such a proof of principle is highly clinically relevant since CST is the 
last resort drug for treatment of KPC-producing MDR K. pneumoniae. Moreover, ST258 is the most commonly 
reported KPC-producing clone associated with colistin resistance39–41.
The SRG dedA had several features that make it an attractive CST “helper” drug target candidate. No 
homology is observed in human proteins, indicating that is safe for use. It is highly conserved across other 
Enterobacteriacae, indicating that is has the potential to be important in conferring resistance across multiple 
bacteria and that its function is non-redundant in K. pneumoniae ST258. The consistent drop in MIC of knockout 
mutants throughout multiple biological replicate experiments supports a low likelihood of the development of 
a spontaneous suppressor mutation of Δ dedA. If a suppressor mutation developed easily, it would have likely 
emerged during exposure of the library to antimicrobials, during the construction of deletion mutants or in the 
culturing step that was used for MIC determination. Furthermore, no additional growth was observed when MIC 
testing plates of the Δ dedA mutant were incubated for multiple days, supporting that DedA plays a specific role 
that cannot be substituted by altering the genome or metabolic network in the studied strain. This is an important 
characteristic that should be considered for any protein as a target for development of innovative antimicrobial 
“helper” drugs able to restore CST susceptibility. Moreover, the lack of fitness cost associated with dedA deletion 
(Fig. S3) suggests that potential helper drugs targeting DedA would have no or very limited antimicrobial activ-
ity, which is another desirable feature for a helper drug, as it minimizes the risk to select helper drug-resistant 
strains. However, the potential use of DedA as a helper drug target needs to be further validated by confirming 
Figure 3. Transposon insertion abundance in dedA at different colistin (CST) concentrations. Transposon 
insertions detected in dedA by Transposon Directed Insertion-site Sequencing (TraDIS) analysis after culture of 
the Klebsiella pneumoniae ST258 mutant library in the presence of 2 or 0.8 μ g/ml of CST and in the absence of 
antibiotic (control).
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the effects of dedA deletion on colistin susceptibility in multiple CST-resistant K. pneumoniae strains with genetic 
backgrounds other than ST258 and with primary CST resistance determinants other than the one observed in 
this clone (i.e. phoQ mutation and an IS insertion in mgrB). In addition, in vitro suppressor mutation frequency 
studies as well as in vivo animal experiments evaluating clinical efficacy of CST in animals challenged with Δ dedA 
mutant are warranted for comprehensive validation of this potential drug target.
To the best of our knowledge, this is the first study identifying the contribution of DedA to CST resistance in 
K. pneumoniae. This result supports the usefulness of TraDIS to identify novel SRGs that have not been previously 
known to be associated with antimicrobial resistance. The dedA gene has never been studied in K. pneumoniae, 
but inactivation of its homologues yqjA and yghB in E. coli has been shown to result in temperature-sensitivity 
and defects in growth42,43. Recent studies in E. coli have shown that DedA homologue YqjA is an inner membrane 
protein with four putative transmembrane domains, which enable growth at high pH and may have roles in drug 
efflux using energy of the membrane proton gradient44–46. YqjA has also been found involved in resistance to the 
antimicrobial peptide magainin in Salmonella enterica47. A dedA family gene has been implicated in resistance 
to antimicrobial peptides in Neisseria meningitidis48. Based on the current knowledge regarding the function of 
DedA-homologs in other species, DedA could be involved in K. pneumoniae membrane biogenesis, lipid A mod-
ification, membrane integrity or efflux. Our finding that dedA deletion specifically restored CST sensitivity in the 
epidemic clone ST258 without changing the MICs of other antimicrobials suggests that the effect of this mutation 
is antibiotic-specific. Further research is needed to elucidate the exact function of this protein in K. pneumoniae, 
its possible involvement in the CST resistance machinery of E. coli and other Gram-negative bacteria, and the 
molecular mechanism of colistin potentiation upon inactivation of dedA.
The limited SR identified by TraDIS for IPM and CIP suggests that the IPM and CIP resistance phenotypes 
in MDR K. pneumoniae ST258, which are conferred by KPC-3 carbapemenase and OqxAB efflux pump, respec-
tively, do not require significant contribution by SRGs at the concentration tested in this study (2 μ g/ml). Notably, 
this concentration is well below the MICs of IPM and CIP in this strain (16 and 32 μ g/ml, respectively) and thus 
may not be sufficient to induce the level of cellular stress required to engage the full SR for these antimicrobials. 
The high MIC of IPM may also explain why the MIC did not change upon nhaA inactivation, despite the 4-fold 
depletion of insertions that was observed by TraDIS analysis following exposure to this drug. Similar changes in 
insertion abundance may reflect subtle differences in mutant fitness under the competitive growth conditions 
tested by TraDIS analysis7. Alternatively, a spontaneous suppressor mutation in the Δ nhaA deletion mutant could 
have restored the IPM resistance phenotype.
In conclusion, this study employed high-throughput, genome-wide antimicrobial-gene interaction profiling of 
MDR K. pneumoniae ST258 to generate an in vitro proof of concept that antimicrobial resistance can be reversed 
by targeting the SR. DedA was proven to be required for growth at therapeutic levels of CST, a key antibiotic for 
management of infections caused by this epidemic clone and other KPC-producing K. pneumoniae strains. The 
findings of the study call for more research to characterize the function of dedA and to assess whether this protein 
can be used as a target for developing helper drugs able to restore CST susceptibility in resistant strains. To date, 
the only antimicrobial helper drugs available in clinical practice are β -lactamase competitive inhibitors such as 
clavulanic acid and sulbactam, which are extensively used in combination with various penicillins (mainly amox-
icillin, ampicillin and ticarcillin) to preserve their activity against bacterial strains that produce β -lactamase49. 
Similar therapeutic strategies based on the use of helper drugs deserve to be further explored to circumvent 
antimicrobial resistance in high-risk MDR clones such as K. pneumoniae ST258.
Methods
WGS of the model strain. The model strain of MDR K. pneumoniae ST258 (RH201207) was isolated from 
a wound infection in the UK. Whole genomic DNA was isolated using a phenol chloroform method and 2 μ g was 
sequenced using the Pacific Biosciences (PacBio) RS II sequencing platform (Manlo Park, CA, USA). DNA was 
sheared to 20 kb and size selection was performed with Magbead (Pacific Biosciences), according to the manufac-
turer’s protocol. The library was sequenced using the P6 chemistry on 3 single-molecule real-time (SMRT) cells. 
Generated sequences were assembled de novo using SMRT analysis pipeline version 2.2.0 integrated with HGAP.3 
(Pacific Biosciences) into 15 contigs. Illumina data (8 million 150 bp paired end reads) from the same genomic 
DNA sample was generated from a MiSeq (Illumina, USA) and was overlaid on these above contigs and 2 single 
nucleotide polymorphisms were identified and resolved using iCORN50.
Four plasmids were identified by in silico alignment to known replicons51 and BLASTn analysis against the 
non-redundant nucleotide NCBI database and consequently split into separate extrachromosomal DNA mole-
cules from the chromosome; contigs per molecule were then annotated using PROKKA52 and finally submitted 
into the European Nucleotide Archive (ENA) under accession numbers for the chromosome and 4 plasmids 
LT216436-LT216440. Antibiotic resistance genes were identified using ResFinder53 and by manual inspection of 
known resistance genes.
Media and reagents. Luria Bertani broth (LB) or agar (LA) were used for routine growth of bacte-
ria. Cation-adjusted Mueller Hinton Broth II (MHB II) was used for antimicrobial susceptibility testing. SOC 
medium54 was prepared and used for the recovery of electroporated cells. All growth media were purchased 
from Becton Dickinson, USA. Tetracycline, aparamycin, hygromycin, CST sulphate, IPM, CIP, ethylenediamine-
tetraacetic acid (EDTA) and isopropyl-thiogalactopyranoside (IPTG) were purchased from Sigma-Aldrich, 
Denmark. Phusion hot start DNA polymerase kit was purchased from Thermo Fisher Scientific, USA. PCR prim-
ers were synthesized by TAG Copenhagen, Denmark. MasterPure Gram Positive DNA Purification Kit was pur-
chased from Epicentre, USA, and sequencing library preparation kits were purchased from Illumina or PacBio, 
USA.
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TraDIS library construction. The tetracycline resistance cassette (TetR) was amplified by PCR from 
pBR32255 (Table S1) using forward and reverse primers (Table S2) 5′ tagged with Tn5 mosaic element and Phusion 
Hot Start DNA Polymerase Kit. PCR product was gel extracted using QIAquick gel extraction kit (Qiagen, 
Europe) and mixed with EZ-Tn5 transposase (Epicenter, USA) and subsequently incubated at 37 °C for 30 min 
to prepare in vitro transposome complex, following manufacturer instructions. LB overnight culture of MDR 
K. pneumoniae ST258 was sub-cultured 1:100 in same fresh media supplemented with 0.7 mM EDTA14. Cells 
in early exponential growth phase were washed once with ice cold water and twice with 10% glycerol to make 
them electrocompetent, and finally re-suspended in 10% glycerol54. Transposase complex was electroporated into 
competent cells and recovered in SOC medium for 1 hour at 37 °C. Subsequently, mutants were selected on LA 
plate supplemented with 10 μ g/ml of tetracycline. To construct > 1 million mutant colonies, this procedure was 
repeated five times and multiple batches of colonies were collected and stored at − 80 °C in 25% glycerol solution.
TraDIS library antimicrobial exposure and sequencing. In duplicate, a 50 μ l aliquot of the library, 
carrying approximately 5 × 107 mutants, was diluted in 10 ml MHB II supplemented 2 μ g/ml of antimicrobial or 
no antimicrobial (control). After 24 h of incubation at 37 °C, 100 μ l of culture were transferred into 9.9 ml of fresh 
medium and incubated again for 24 h, and a 1 ml aliquot from each sub-culture was centrifuged at 10 000 rpm for 
2 min. The resulting pellet was used for total DNA isolation using MasterPure Gram Positive DNA Purification 
Kit following manufacturer’s instructions. The quality of isolated DNA was evaluated using NanoDrop (Thermo 
Scientific, USA) and concentration of DNA was measured using Qubit dsDNA HS Assay Kit (Thermo Fisher 
Scientific, USA). For TraDIS sequencing, 2 μ g of DNA was used for library construction following protocol 
described in the TraDIS Toolkit method56, using oligonucleotides (Table S2) specific for PCR enrichment of 
transposon insertion sites (DNA fragments tagged with transposon). Multiple PCR amplified fragment libraries 
were pooled and sequenced on a HiSeq2500 using an optimized TraDIS recipe57, yielding 32 million reads.
TraDIS data analysis. Sequences containing the transposon tag were mapped against the RH201207 ref-
erence genome, using the Bio::TraDIS pipeline (https://github.com/sanger-pathogens/Bio-Tradis) to determine 
numbers of transposon insertions per gene. For each gene, an ‘insertion index’ was calculated so that the number 
of insertions in each gene was divided by total gene length, excluding 10% of the 3, end56. A histogram of insertion 
indices showed a bimodal distribution and gamma distributions were fitted to define the 2 nodes as the essential 
and non-essential genes. The log2-likelihood ratios for each gene were calculated, and considered essential if it 
was at least log2FC under the essential insertion index distribution, non-essential if it was at least log2FC likely 
to be under the non-essential insertion index distribution, as described previously in Dembek et al.10. Here, 
the essentiality cut-off was set at an insertion index of 0.0082 or and ambiguous gene fell between this and the 
non-essentiality cut-off of 0.013. Statistical analysis was performed in R. Read counts were normalized using the 
trimmed mean of M (TMM) method, and differences in insertions between antimicrobial exposed and unex-
posed samples were tested for statistical significance using the edgeR package version 3.4.2, as described previ-
ously56. We defined SRGs as genes with a log2FC change read counts of ≤ − 2 (≥ 4 fold change) at a False Discovery 
Rate (FDR) of 5%, which corresponds to q value ≤ 0.01. When multiple SRGs were placed on the same operon, 
the first structural gene was considered as representative of the entire operon in order to avoid redundancy from 
potential polar effects. The TraDIS sequencing data is published in the European Nucleotide Archive, under the 
accession numbers given in Table S3. Further, the read counts, mapping statistics and transposon prevalence 
information for each sample is also given in Table S3.
Deletion of gene in MDR K. pneumoniae ST258. The genes identified by TraDIS were substituted indi-
vidually by the TetR resistance cassette using lambda red recombinase tools35 that have been recently optimized for 
K. pneumoniae gene deletion36. First, a TetR cassette was cloned in the middle of two Flippase Recognition Targets 
(FRT) by substituting the chloramphenicol resistance cassette (CamR) of pKD3-CamR35 with TetR (Table S1). To 
swap the resistance markers, TetR cassette from pBR322 and the pKD3-CamR plasmid backbone, excluding CamR 
cassette, were amplified individually using two oligo pairs, oKD3-F/oKD3-R and otetR-F/otetR-R (Table S2), 
respectively, and fragments were ligated through blunt-end ligation using T4 ligase (Thermo Scientific, USA), 
resulting in the construction of pKD3-TetR (Table S1). For gene deletion, the TetR cassette was PCR amplified 
using primers (Table S2) attached with 59 bases homologous to the up- or down-stream sequence of the target 
gene and the resulting PCR product was purified by gel extraction. Temperature-sensitive lambda red recombi-
nase plasmid (Table S1) was transformed into electrocompetent MDR K. pneumoniae ST258 and selected on LB 
plate containing 100 μ g/ml hygromycin. The transformant was grown at 30 °C in LB supplemented with 0.7 mM 
EDTA and hygromycin. The recombinase genes were induced with 100 mM arabinose and induced cells were 
made electrocompetent. Purified TetR cassette was electroporated to competent cells and recovered at 37 °C for 
2 hours. Finally, recombined mutant was selected on LA plate supplemented with 10 μ g/ml tetracycline. Gene 
deletion was confirmed by PCR amplification and sequencing (Macrogen, Europe).
Antimicrobial susceptibility testing of wild type and mutants. Antimicrobial susceptibility testing 
was performed by broth microdilution following CLSI standards18. MICs were recorded after 18 h of incubation 
at 37 °C.
In silico homology study of proteins DedA. Bioinformatics analysis of DedA was performed follow-
ing published analysis pipeline58. RH201207 annotated DedA protein sequence was taken from Artemis and 
sequence similarity with human protein was searched using NCBI Homo sapiens (human) Protein BLAST tools 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). Similarly, NCBI/BLAST/blastp suite tools were used to search sequence 
homology of DedA with protein sequences from different clinically relevant Enterobacteriaceae species. Four 
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clinically relevant Enterobacteriaceae species (Salmonella enterica, Shigella flexneri, Citrobacter freundii, and 
Escherichia coli) were added in the analysis pipeline manually.
Cloning of K. pneumoniae dedA. The K. pneumoniae dedA gene (KpndedA) was amplified from 
RH201207 genomic DNA using primers KdedA1 and KdedA2 (Table S2), digested with SacI and HindIII (New 
England Biolabs, UAS) and ligated with a similarly digested and dephosphorylated linearized fragment of vector 
pBAD-HisA (Invitrogen, USA) to construct plasmid pBAD-KpndedA. Since studied K. pneumoniae ST258 is 
resistant to ampicillin, the selection marker of both vector and clone was replaced by the apramycin resistance 
cassette of pIJ773. For this, both plasmids pBAD-HisA and pBAD-KpndedA were amplified using primers Bad1 
and Bad2 (Table S2), digested with XbaI and dephosphorylated with Antartic phosphatase (New England Biolabs, 
USA) resulting in the linearized plasmid minus the AmpR cassette. In parallel, the AprR cassette of pIJ773 was 
amplified using primers Apr1 and Apr2, digested with XbaI and ligated separately with the linearized plasmids 
described above using T4 ligase (Thermo Scientific, USA). Plasmids with ApaR resistance marker were selected on 
LB agar plate supplemented with 50 μ g/ml apramycin and KpnDedA protein was expressed using 0.002 to 0.1% 
arabinose inducer.
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